Omega Funds

Omega Funds company information, Employees & Contact Information

Explore related pages

Related company profiles:

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised approximately $2.5 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA. Please be mindful of scams presented by unauthorized individuals regarding fictitious positions, job offers and other misrepresentations. We do not ask candidates to provide sensitive identifiable information via email. If a person claiming to be an Omega recruiter reaches out to you regarding a job opportunity, please report it to our team by emailing dac@omegafunds.com with the details.

Company Details

Employees
34
Founded
-
Address
888 Boylston St, Boston,massachusetts 02199,united States
Email
in****@****nds.net
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Boston, Massachusetts
Looking for a particular Omega Funds employee's phone or email?

Omega Funds Questions

News

Biotech VC Omega Funds raises $647 million fund - statnews.com

Biotech VC Omega Funds raises $647 million fund statnews.com

Life sciences VC Omega Funds closes $647m funding round - Pharmaceutical Technology

Life sciences VC Omega Funds closes $647m funding round Pharmaceutical Technology

Omega Funds Closes $647 Million Fund VIII - citybiz

Omega Funds Closes $647 Million Fund VIII citybiz

Omega Funds raises $647m for eighth fund - Venture Capital Journal

Omega Funds raises $647m for eighth fund Venture Capital Journal

Omega Funds: $647 Million Fund VIII Closed To Invest In Life Science Companies - Pulse 2.0

Omega Funds: $647 Million Fund VIII Closed To Invest In Life Science Companies Pulse 2.0

Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking Obesity Treatment - PR Newswire

Ousia Pharma Secures Substantial Seed Financing Led by Omega Funds to Advance Groundbreaking Obesity Treatment PR Newswire

Omega Funds Announces the Promotion of Francesco Draetta to Managing Director - Business Wire

Omega Funds Announces the Promotion of Francesco Draetta to Managing Director Business Wire

A top biotech VC is advising his companies to delay IPOs, saying going public now is 'insane' - businessinsider.com

A top biotech VC is advising his companies to delay IPOs, saying going public now is 'insane' businessinsider.com

Q&A with founder of Omega Funds, the reclusive VC firm behind Juno, Gossamer Bio, and Editas - MedCity News

Q&A with founder of Omega Funds, the reclusive VC firm behind Juno, Gossamer Bio, and Editas MedCity News

Oncology Start-Up Nuvation Bio Closes $275 Million Series A Financing Led by Omega Funds - PR Newswire

Oncology Start-Up Nuvation Bio Closes $275 Million Series A Financing Led by Omega Funds PR Newswire

Top Omega Funds Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant